治理


We apply all the main and supporting principles of good corporate governance in the UK Corporate 治理 Code (formerly the Combined Code) and related guidance.


管理文档

员工的股票期权

董事的持股

AstraZeneca’s Board and executive committee receive shares in the Company as part of their compensation to help align their interests with those of shareholders. 阅读更多 in our Annual Report and Form 20-F Information for 2022. 

审计人员

AstraZeneca’s independent external auditor is elected each year by the shareholders at the Annual General Meeting.
 
At present our auditors are PricewaterhouseCooper LLP).
 
PricewaterhouseCooper LLP)
1路堤坊
伦敦
中移动WC2N 6


公司治理

As a foreign issuer with American Depositary Shares listed on Nasdaq, we must also disclose any significant ways in which our corporate governance practices differ from those followed by US companies under Nasdaq’s corporate governance listing standards.

Information on our corporate governance performance can be found in our 年度报告.


董事会

We have a highly experienced Board and Senior Executive Team. 董事会 is responsible for the Group's corporate governance, sets the Group's strategy and policies, has overall responsibility for the oversight of risk and also monitors progress towards meeting its strategic objectives and annual plans. 董事会 discharges these responsibilities through a programme of meetings that includes a formal, 年度策略检讨. 董事会 also assesses whether or not, 到什么程度, its obligations to the Company's shareholders and other stakeholders are understood and met. This includes regular reviews of the Group's financial performance and critical business issues.

更多的 information on the principle roles and responsibilities of our Board can be found in the corporate governance section of our latest Annual Report.

The terms and conditions of appointment of Non-Executive Directors are available to view and download here: